{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-18T19:47:18.746636+00:00","published_at":"2026-10-18T07:11:41.113957+00:00","section":"relationships","data":{"state":"PUBLISHED","relationships":[{"relationship_id":"alpha:relationship:seat_on:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:leadership_role:5:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","relationship_type":"seat_on","from_id":"alpha:person:bernhardt-zeiher-m-d","to_id":"alpha:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","from_label":"Bernhardt Zeiher, M.D.","to_label":"Amylyx Pharmaceuticals, Inc.","valid_from":"2024-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:leadership_role:5","evidence_ids":["alpha:projection-evidence:document:1d23bd4956a675ce7d5dafcda0eb5dedf30f24464aba0c2cb8f6f110c1072796"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:leadership_role:6:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","relationship_type":"seat_on","from_id":"alpha:person:daphne-quimi","to_id":"alpha:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","from_label":"Daphne Quimi","to_label":"Amylyx Pharmaceuticals, Inc.","valid_from":"2021-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:leadership_role:6","evidence_ids":["alpha:projection-evidence:document:1d23bd4956a675ce7d5dafcda0eb5dedf30f24464aba0c2cb8f6f110c1072796"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:leadership_role:7:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","relationship_type":"seat_on","from_id":"alpha:person:george-mclean-milne-jr-ph-d","to_id":"alpha:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","from_label":"George Mclean Milne Jr., Ph.D.","to_label":"Amylyx Pharmaceuticals, Inc.","valid_from":"2015-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:leadership_role:7","evidence_ids":["alpha:projection-evidence:document:1d23bd4956a675ce7d5dafcda0eb5dedf30f24464aba0c2cb8f6f110c1072796"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:leadership_role:8:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","relationship_type":"seat_on","from_id":"alpha:person:joshua-cohen","to_id":"alpha:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","from_label":"Joshua Cohen","to_label":"Amylyx Pharmaceuticals, Inc.","valid_from":"2014-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:1d23bd4956a675ce7d5dafcda0eb5dedf30f24464aba0c2cb8f6f110c1072796"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:leadership_role:9:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","relationship_type":"seat_on","from_id":"alpha:person:justin-klee","to_id":"alpha:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","from_label":"Justin Klee","to_label":"Amylyx Pharmaceuticals, Inc.","valid_from":"2014-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:1d23bd4956a675ce7d5dafcda0eb5dedf30f24464aba0c2cb8f6f110c1072796"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:leadership_role:10:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","relationship_type":"seat_on","from_id":"alpha:person:karen-firestone","to_id":"alpha:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","from_label":"Karen Firestone","to_label":"Amylyx Pharmaceuticals, Inc.","valid_from":"2023-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:1d23bd4956a675ce7d5dafcda0eb5dedf30f24464aba0c2cb8f6f110c1072796"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:leadership_role:11:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","relationship_type":"seat_on","from_id":"alpha:person:paul-fonteyne","to_id":"alpha:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","from_label":"Paul Fonteyne","to_label":"Amylyx Pharmaceuticals, Inc.","valid_from":"2021-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:1d23bd4956a675ce7d5dafcda0eb5dedf30f24464aba0c2cb8f6f110c1072796"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:committee_record:12:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","relationship_type":"committee_of","from_id":"alpha:committee:amylyx-pharmaceuticals-inc:audit","to_id":"alpha:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","from_label":"Audit","to_label":"Amylyx Pharmaceuticals, Inc.","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:committee_record:12","evidence_ids":["alpha:projection-evidence:bfb084d3eef65665fe18bb14a8a8bdee118c3fee2714f5943612c55e87421cc6"]},{"relationship_id":"alpha:relationship:chairs:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:committee_record:12:committee:amylyx-pharmaceuticals-inc:audit","relationship_type":"chairs","from_id":"alpha:person:daphne-quimi","to_id":"alpha:committee:amylyx-pharmaceuticals-inc:audit","from_label":"Daphne Quimi","to_label":"Audit","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:committee_record:12","evidence_ids":["alpha:projection-evidence:bfb084d3eef65665fe18bb14a8a8bdee118c3fee2714f5943612c55e87421cc6"]},{"relationship_id":"alpha:relationship:member_of:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:committee_record:12:committee:amylyx-pharmaceuticals-inc:audit","relationship_type":"member_of","from_id":"alpha:person:karen-firestone","to_id":"alpha:committee:amylyx-pharmaceuticals-inc:audit","from_label":"Karen Firestone","to_label":"Audit","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:committee_record:12","evidence_ids":["alpha:projection-evidence:bfb084d3eef65665fe18bb14a8a8bdee118c3fee2714f5943612c55e87421cc6"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:leadership_role:6:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","relationship_type":"committee_of","from_id":"alpha:committee:amylyx-pharmaceuticals-inc:audit-chair-compensation","to_id":"alpha:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","from_label":"Audit · Chair; Compensation","to_label":"Amylyx Pharmaceuticals, Inc.","valid_from":"2021-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:leadership_role:6","evidence_ids":["alpha:projection-evidence:document:1d23bd4956a675ce7d5dafcda0eb5dedf30f24464aba0c2cb8f6f110c1072796"]},{"relationship_id":"alpha:relationship:member_of:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:leadership_role:6:committee:amylyx-pharmaceuticals-inc:audit-chair-compensation","relationship_type":"member_of","from_id":"alpha:person:daphne-quimi","to_id":"alpha:committee:amylyx-pharmaceuticals-inc:audit-chair-compensation","from_label":"Daphne Quimi","to_label":"Audit · Chair; Compensation","valid_from":"2021-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:leadership_role:6","evidence_ids":["alpha:projection-evidence:document:1d23bd4956a675ce7d5dafcda0eb5dedf30f24464aba0c2cb8f6f110c1072796"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:leadership_role:10:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","relationship_type":"committee_of","from_id":"alpha:committee:amylyx-pharmaceuticals-inc:audit-nominating-and-governance","to_id":"alpha:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","from_label":"Audit; Nominating and Governance","to_label":"Amylyx Pharmaceuticals, Inc.","valid_from":"2023-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:1d23bd4956a675ce7d5dafcda0eb5dedf30f24464aba0c2cb8f6f110c1072796"]},{"relationship_id":"alpha:relationship:member_of:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:leadership_role:10:committee:amylyx-pharmaceuticals-inc:audit-nominating-and-governance","relationship_type":"member_of","from_id":"alpha:person:karen-firestone","to_id":"alpha:committee:amylyx-pharmaceuticals-inc:audit-nominating-and-governance","from_label":"Karen Firestone","to_label":"Audit; Nominating and Governance","valid_from":"2023-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:1d23bd4956a675ce7d5dafcda0eb5dedf30f24464aba0c2cb8f6f110c1072796"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:committee_record:15:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","relationship_type":"committee_of","from_id":"alpha:committee:amylyx-pharmaceuticals-inc:compensation","to_id":"alpha:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","from_label":"Compensation","to_label":"Amylyx Pharmaceuticals, Inc.","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:committee_record:15","evidence_ids":["alpha:projection-evidence:bfb084d3eef65665fe18bb14a8a8bdee118c3fee2714f5943612c55e87421cc6"]},{"relationship_id":"alpha:relationship:chairs:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:committee_record:15:committee:amylyx-pharmaceuticals-inc:compensation","relationship_type":"chairs","from_id":"alpha:person:paul-fonteyne","to_id":"alpha:committee:amylyx-pharmaceuticals-inc:compensation","from_label":"Paul Fonteyne","to_label":"Compensation","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:committee_record:15","evidence_ids":["alpha:projection-evidence:bfb084d3eef65665fe18bb14a8a8bdee118c3fee2714f5943612c55e87421cc6"]},{"relationship_id":"alpha:relationship:member_of:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:committee_record:15:committee:amylyx-pharmaceuticals-inc:compensation","relationship_type":"member_of","from_id":"alpha:person:daphne-quimi","to_id":"alpha:committee:amylyx-pharmaceuticals-inc:compensation","from_label":"Daphne Quimi","to_label":"Compensation","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:committee_record:15","evidence_ids":["alpha:projection-evidence:bfb084d3eef65665fe18bb14a8a8bdee118c3fee2714f5943612c55e87421cc6"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:leadership_role:11:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","relationship_type":"committee_of","from_id":"alpha:committee:amylyx-pharmaceuticals-inc:compensation-chair","to_id":"alpha:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","from_label":"Compensation · Chair","to_label":"Amylyx Pharmaceuticals, Inc.","valid_from":"2021-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:1d23bd4956a675ce7d5dafcda0eb5dedf30f24464aba0c2cb8f6f110c1072796"]},{"relationship_id":"alpha:relationship:member_of:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:leadership_role:11:committee:amylyx-pharmaceuticals-inc:compensation-chair","relationship_type":"member_of","from_id":"alpha:person:paul-fonteyne","to_id":"alpha:committee:amylyx-pharmaceuticals-inc:compensation-chair","from_label":"Paul Fonteyne","to_label":"Compensation · Chair","valid_from":"2021-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:1d23bd4956a675ce7d5dafcda0eb5dedf30f24464aba0c2cb8f6f110c1072796"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:committee_record:18:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","relationship_type":"committee_of","from_id":"alpha:committee:amylyx-pharmaceuticals-inc:nominating-and-governance","to_id":"alpha:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","from_label":"Nominating and Governance","to_label":"Amylyx Pharmaceuticals, Inc.","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:committee_record:18","evidence_ids":["alpha:projection-evidence:bfb084d3eef65665fe18bb14a8a8bdee118c3fee2714f5943612c55e87421cc6"]},{"relationship_id":"alpha:relationship:member_of:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:committee_record:18:committee:amylyx-pharmaceuticals-inc:nominating-and-governance","relationship_type":"member_of","from_id":"alpha:person:karen-firestone","to_id":"alpha:committee:amylyx-pharmaceuticals-inc:nominating-and-governance","from_label":"Karen Firestone","to_label":"Nominating and Governance","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:committee_record:18","evidence_ids":["alpha:projection-evidence:bfb084d3eef65665fe18bb14a8a8bdee118c3fee2714f5943612c55e87421cc6"]}]},"claims":[{"id":"alpha:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:leadership_role:5","subject_id":"alpha:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:bernhardt-zeiher-m-d","object_label":"Bernhardt Zeiher, M.D.","object_source_name_forms":[],"value":"Bernhardt Zeiher, M.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:bernhardt-zeiher-m-d","name":"Bernhardt Zeiher, M.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-18T07:11:41.113957+00:00","sources":[{"id":"alpha:projection-evidence:document:1d23bd4956a675ce7d5dafcda0eb5dedf30f24464aba0c2cb8f6f110c1072796","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Amylyx Pharmaceuticals, Inc. DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm","source_date":"2026-04-23","retrieved_at":"2026-04-24T15:47:01.041+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-18T07:11:41.113957+00:00","reviewed_at":"2026-10-18T07:11:41.113957+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:leadership_role:6","subject_id":"alpha:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:daphne-quimi","object_label":"Daphne Quimi","object_source_name_forms":[],"value":"Daphne Quimi: Director, Audit · Chair; Compensation","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:daphne-quimi","name":"Daphne Quimi"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-18T07:11:41.113957+00:00","sources":[{"id":"alpha:projection-evidence:document:1d23bd4956a675ce7d5dafcda0eb5dedf30f24464aba0c2cb8f6f110c1072796","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Amylyx Pharmaceuticals, Inc. DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm","source_date":"2026-04-23","retrieved_at":"2026-04-24T15:47:01.041+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-18T07:11:41.113957+00:00","reviewed_at":"2026-10-18T07:11:41.113957+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:leadership_role:7","subject_id":"alpha:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:george-mclean-milne-jr-ph-d","object_label":"George Mclean Milne Jr., Ph.D.","object_source_name_forms":[],"value":"George Mclean Milne Jr., Ph.D.: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:george-mclean-milne-jr-ph-d","name":"George Mclean Milne Jr., Ph.D."},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2015-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2015-01-01","valid_to":null,"recorded_at":"2026-10-18T07:11:41.113957+00:00","sources":[{"id":"alpha:projection-evidence:document:1d23bd4956a675ce7d5dafcda0eb5dedf30f24464aba0c2cb8f6f110c1072796","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Amylyx Pharmaceuticals, Inc. DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm","source_date":"2026-04-23","retrieved_at":"2026-04-24T15:47:01.041+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2015-01-01","effective_until":null,"observed_at":"2026-10-18T07:11:41.113957+00:00","reviewed_at":"2026-10-18T07:11:41.113957+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:leadership_role:8","subject_id":"alpha:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:joshua-cohen","object_label":"Joshua Cohen","object_source_name_forms":[],"value":"Joshua Cohen: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:joshua-cohen","name":"Joshua Cohen"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2014-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2014-01-01","valid_to":null,"recorded_at":"2026-10-18T07:11:41.113957+00:00","sources":[{"id":"alpha:projection-evidence:document:1d23bd4956a675ce7d5dafcda0eb5dedf30f24464aba0c2cb8f6f110c1072796","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Amylyx Pharmaceuticals, Inc. DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm","source_date":"2026-04-23","retrieved_at":"2026-04-24T15:47:01.041+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2014-01-01","effective_until":null,"observed_at":"2026-10-18T07:11:41.113957+00:00","reviewed_at":"2026-10-18T07:11:41.113957+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:leadership_role:9","subject_id":"alpha:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:justin-klee","object_label":"Justin Klee","object_source_name_forms":[],"value":"Justin Klee: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:justin-klee","name":"Justin Klee"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2014-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2014-01-01","valid_to":null,"recorded_at":"2026-10-18T07:11:41.113957+00:00","sources":[{"id":"alpha:projection-evidence:document:1d23bd4956a675ce7d5dafcda0eb5dedf30f24464aba0c2cb8f6f110c1072796","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Amylyx Pharmaceuticals, Inc. DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm","source_date":"2026-04-23","retrieved_at":"2026-04-24T15:47:01.041+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2014-01-01","effective_until":null,"observed_at":"2026-10-18T07:11:41.113957+00:00","reviewed_at":"2026-10-18T07:11:41.113957+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:leadership_role:10","subject_id":"alpha:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:karen-firestone","object_label":"Karen Firestone","object_source_name_forms":[],"value":"Karen Firestone: Director, Audit; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:karen-firestone","name":"Karen Firestone"},"title":"Director","role_category":"director","committee":"Audit; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-18T07:11:41.113957+00:00","sources":[{"id":"alpha:projection-evidence:document:1d23bd4956a675ce7d5dafcda0eb5dedf30f24464aba0c2cb8f6f110c1072796","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Amylyx Pharmaceuticals, Inc. DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm","source_date":"2026-04-23","retrieved_at":"2026-04-24T15:47:01.041+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-18T07:11:41.113957+00:00","reviewed_at":"2026-10-18T07:11:41.113957+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:leadership_role:11","subject_id":"alpha:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:paul-fonteyne","object_label":"Paul Fonteyne","object_source_name_forms":[],"value":"Paul Fonteyne: Director, Compensation · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:paul-fonteyne","name":"Paul Fonteyne"},"title":"Director","role_category":"director","committee":"Compensation · Chair","is_board_chair":false,"is_independent":true,"start_date":"2021-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2021-01-01","valid_to":null,"recorded_at":"2026-10-18T07:11:41.113957+00:00","sources":[{"id":"alpha:projection-evidence:document:1d23bd4956a675ce7d5dafcda0eb5dedf30f24464aba0c2cb8f6f110c1072796","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Amylyx Pharmaceuticals, Inc. DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm","source_date":"2026-04-23","retrieved_at":"2026-04-24T15:47:01.041+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-23","effective_from":"2021-01-01","effective_until":null,"observed_at":"2026-10-18T07:11:41.113957+00:00","reviewed_at":"2026-10-18T07:11:41.113957+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:committee_record:12","subject_id":"alpha:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair Daphne Quimi; Members Daphne Quimi (Chair); Karen Firestone","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":"Daphne Quimi","members":[{"display_name":"Daphne Quimi","person_slug":"daphne-quimi","is_chair":true},{"display_name":"Karen Firestone","person_slug":"karen-firestone","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-18T07:11:41.113957+00:00","sources":[{"id":"alpha:projection-evidence:bfb084d3eef65665fe18bb14a8a8bdee118c3fee2714f5943612c55e87421cc6","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-18T07:11:41.113957+00:00","reviewed_at":"2026-10-18T07:11:41.113957+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:committee_record:15","subject_id":"alpha:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compensation: Chair Paul Fonteyne; Members Paul Fonteyne (Chair); Daphne Quimi","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compensation","canonical_type":"compensation","chair":"Paul Fonteyne","members":[{"display_name":"Paul Fonteyne","person_slug":"paul-fonteyne","is_chair":true},{"display_name":"Daphne Quimi","person_slug":"daphne-quimi","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-18T07:11:41.113957+00:00","sources":[{"id":"alpha:projection-evidence:bfb084d3eef65665fe18bb14a8a8bdee118c3fee2714f5943612c55e87421cc6","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-18T07:11:41.113957+00:00","reviewed_at":"2026-10-18T07:11:41.113957+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa:committee_record:18","subject_id":"alpha:company:ff2d5a37-e808-42b8-ac38-9a58a3e11cfa","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Nominating and Governance: Chair not stated; Members Karen Firestone","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Nominating and Governance","canonical_type":"nominating_governance","chair":null,"members":[{"display_name":"Karen Firestone","person_slug":"karen-firestone","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-18T07:11:41.113957+00:00","sources":[{"id":"alpha:projection-evidence:bfb084d3eef65665fe18bb14a8a8bdee118c3fee2714f5943612c55e87421cc6","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-18T07:11:41.113957+00:00","reviewed_at":"2026-10-18T07:11:41.113957+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:1d23bd4956a675ce7d5dafcda0eb5dedf30f24464aba0c2cb8f6f110c1072796","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Amylyx Pharmaceuticals, Inc. DEF 14A 2026-04-23","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm","source_date":"2026-04-23","retrieved_at":"2026-04-24T15:47:01.041+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:bfb084d3eef65665fe18bb14a8a8bdee118c3fee2714f5943612c55e87421cc6","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/1658551/000119312526171800/amlx-20260422.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.834,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.863,"cross_source_agreement":0.75,"temporal_completeness":0.583},"diagnostics":{"published_claims":19,"factual_claims":19,"claims_with_linked_evidence":19,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":12,"temporal_claims_with_valid_from":7,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","executive_role","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-18T07:11:41.113957+00:00","observed_at":"2026-10-18T07:11:41.113957+00:00","reviewed_at":"2026-10-18T07:11:41.113957+00:00","verified_at":"2026-10-18T07:11:41.113957+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":19,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/amylyx-pharmaceuticals-inc/relationships","section":"relationships","href":"https://registry.alpha.ac/api/public/companies/amylyx-pharmaceuticals-inc?format=record&section=relationships","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}